Idaho Sci-Tech Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.

Press releases published on November 9, 2026

37 minutes ago

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

37 minutes ago

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

37 minutes ago

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire

37 minutes ago

Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman

Indeterminate GlobeNewswire

37 minutes ago

Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year

Indeterminate GlobeNewswire

37 minutes ago

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Indeterminate GlobeNewswire

37 minutes ago

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Indeterminate GlobeNewswire

37 minutes ago

Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

37 minutes ago

BlossomHill Therapeutics Announces Outcome from the End-of-Phase 1 Meeting with the FDA and Pivotal Phase 2 Trial Design for OMNI-EGFR™ Inhibitor, BH-30643, in EGFR C797S-Positive NSCLC

Indeterminate GlobeNewswire

37 minutes ago

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

37 minutes ago

Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network

Indeterminate GlobeNewswire

37 minutes ago

Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast

Indeterminate GlobeNewswire

37 minutes ago

Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

Indeterminate GlobeNewswire

37 minutes ago

Medicenna Presents ABILITY-1 Data at SITC 2026 Showing 40% ORR in Gastrointestinal Cancer Patients with Biomarker Enriched Tumors Resistant to Approved Therapies

Indeterminate GlobeNewswire

an hour ago

Abeona Therapeutics® Reports Third Quarter 2026 Financial Results and ZEVASKYN® Commercial Progress

Indeterminate GlobeNewswire

an hour ago

Abeona Therapeutics® Acquires Phase 3-Ready APT-1011, Now ABO-801, and Enters Into Agreement for $30 Million Private Placement

Indeterminate GlobeNewswire

an hour ago

Meowant Announces Black Friday and Cyber Monday Sale With Upgraded Offers at Meowant.com

Indeterminate GlobeNewswire

2 hours ago

DeepLife and 3billion partner to discover small-molecule therapeutics against genetic modifier targets across multiple diseases

Indeterminate GlobeNewswire

2 hours ago

Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Edesa Biotech Announces Agreement with KYORIN Pharmaceutical to Develop and Commercialize Paridiprubart in Japan

Indeterminate GlobeNewswire